Compare McKesson Corporation (MCK) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs State Street Real Estate Select Sector SPDR ETF — how do they compare? McKesson Corporation trades at $828.09 (market cap $97.35B), while State Street Real Estate Select Sector SPDR ETF trades at $45.23. The key difference: McKesson Corporation pays a 0.39% dividend while State Street Real Estate Select Sector SPDR ETF pays none, and State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, McKesson Corporation nearer its low. Which is the better fit depends on your goals.
| MCK | XLRE | |
|---|---|---|
Market Cap | $97.35B | — |
Sector | Health | Sector/Thematic |
52-Week High | $995.69 | $45.46 |
52-Week Low | $659.01 | $40.01 |
Enterprise Value | $101.98B | — |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
XLRE, the Real Estate Select Sector SPDR ETF, trades at $45.23, down 0.42% on the day, while maintaining a bullish technical trend per moving averages. The fund's low 0.08% expense ratio and 3.4% trailing yield appeal to cost-conscious income investors. Recent news highlights a quiet revival in REIT ETFs, with XLRE gaining 11% year-to-date as of late May 2026, defying broader rate pressures amid shifting Fed expectations.
The outlook for XLRE is cautiously optimistic, supported by solid REIT fundamentals and potential as a geopolitical hedge. Key opportunities include attractive valuations and dividend sustainability, but risks persist from interest rate volatility and inflation concerns that could pressure real estate valuations and investor sentiment in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
